Oppenheimer Raises Amdocs (NASDAQ:DOX) Price Target to $105.00

Amdocs (NASDAQ:DOX) had its price objective boosted by Oppenheimer from $98.00 to $105.00 in a report published on Wednesday,Benzinga reports. The brokerage currently has an outperform rating on the technology company’s stock.

Several other analysts have also recently weighed in on the stock. Stifel Nicolaus began coverage on shares of Amdocs in a report on Wednesday, October 2nd. They issued a “buy” rating and a $100.00 price target on the stock. StockNews.com raised shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 25th. One analyst has rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, Amdocs currently has a consensus rating of “Buy” and an average target price of $101.83.

Amdocs Trading Down 1.5 %

Shares of DOX stock traded down $1.31 during trading hours on Wednesday, reaching $86.44. The company’s stock had a trading volume of 95,033 shares, compared to its average volume of 676,475. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. Amdocs has a one year low of $74.41 and a one year high of $94.04. The stock has a market capitalization of $10.16 billion, a P/E ratio of 20.70, a P/E/G ratio of 1.50 and a beta of 0.74. The firm’s fifty day simple moving average is $88.16 and its 200 day simple moving average is $83.92.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the business. Private Trust Co. NA raised its stake in Amdocs by 62.9% during the third quarter. Private Trust Co. NA now owns 303 shares of the technology company’s stock valued at $27,000 after buying an additional 117 shares during the last quarter. Brooklyn Investment Group bought a new position in shares of Amdocs during the third quarter valued at $28,000. Catalyst Capital Advisors LLC purchased a new position in shares of Amdocs in the 3rd quarter worth about $55,000. GAMMA Investing LLC boosted its stake in Amdocs by 115.1% in the 3rd quarter. GAMMA Investing LLC now owns 800 shares of the technology company’s stock worth $70,000 after purchasing an additional 428 shares in the last quarter. Finally, American National Bank purchased a new stake in Amdocs during the 2nd quarter valued at about $76,000. 92.02% of the stock is currently owned by institutional investors.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.